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INTRODUCTION
Rickettsial infections are widely distributed
throughout the world [1]. In Tunisia, Mediterra-
nean spotted fever (MSF) is the most common
rickettsiosis and is a frequent cause of hospitali-
sation [2]. However, other rickettsial infections
have been reported [3]. The aim of this study was
to determine the different aetiologic agents and
their epidemiological, clinical, laboratory and
therapeutic characteristics in patients with rick-
ettsial infections.
METHODS
We conducted a retrospective study of rickettsial disease in a
hospital-based population at the Infectious Diseases Unit of
the University Hospital in Sousse (central Tunisia) between
January 2000 and December 2007.
Among 269 patients with acute fever of undetermined
origin, we included only those having proven rickettsial
infections. The diagnosis of rickettsiosis was conﬁrmed by
either clinical criteria or positive serology [4]. Blood samples
were collected from 88 patients. Fifty-nine patients had one
blood sample and 29 patients had two blood samples. Sera of
all patients were tested for the presence of antibodies to
Rickettsia conorii in the Department of Microbiology in our
hospital. Moreover, sera of 24 patients were tested in a
multiple-antigen immunoﬂuorescence assay (IFA) to detect
antibodies against R. conorii, R. africae, R. sibirica mongolotim-
onae, R. aeschlimannii, R. massiliae, R. helvetica, R. slovaca, R. felis
and R. typhi, Coxiella burnetii, Bartonella henselae, Bartonella
quintana and human granulocytic anaplasma, in the Unite´ des
Rickettsies, Faculte´ de Me´decine Marseille-France. Serology
was considered positive in case of: (i) IgG titres >1 ⁄ 80 and ⁄ or
IgM > 1 ⁄ 32, (ii) seroconversion, or (iii) fourfold or higher
increase in IgG titres. Identiﬁcation of species of Rickettsia was
performed by Western immunoblotting (WB) procedures. Skin
biopsy for PCR ampliﬁcation and cultivation of Rickettsiae was
carried out in 14 patients. Cell culture and PCR ampliﬁcation
were performed in one tick (Rhipicephalus sanguineus) found on
a patient’s dog.
RESULTS
Epidemiological, clinical and laboratory data
During the study period, 119 patients, 73 male
and 46 female, mean age = 39 years (range,
16–76), were admitted into our department with
the diagnosis of rickettsiosis. Diagnosis was con-
ﬁrmed by serology in 88 cases and by clinical
criteria in 21 cases. An average of 15 patients per
year was observed, which represents 3% of
admissions, 90% of cases occurring between
May and October. One hundred and twelve
patients (94.5%) had contact with domestic ani-
mals. The most common clinical ﬁndings were
fever, present in all cases, skin rash in 86.4% and
headache in 69.5% of cases. The clinical triad was
noted in 38 cases (32%). Skin rash, which
appeared 5 days after onset of fever, involved
the palms and soles in 42 cases (41%), and face in
ﬁve cases (5%). Eschar was present in 38 cases
(32%). It was solitary in 33 cases (86.8%) and
multiple in ﬁve cases (13.2%). The main sites of
eschar were limbs (16 cases), genital organs (ﬁve
cases), buttocks (four cases) and abdomen (four
cases). Twenty-two patients had conjunctivitis.
Clinical data are summarised in Table 1.
Laboratory ﬁndings showed normal WBC cell
count or leucopenia in 79 cases (67.5%), thromb-
openia in 50 cases (43.9%) and elevated liver
enzymes (ALAT and ⁄ or ASAT) in 69 cases
(62.2%).
MSF was the most frequent rickettsiosis (62
cases, 47 of which were conﬁrmed by serology
and 15 by clinical criteria), followed by endemic
(murine) typhus (12 cases) and other undeter-
mined SFG and ⁄ or typhus group rickettsioses (45
cases, one of which was due to Rickettsia felis). Six
patients (5%) had co-infection with R. conorii and
Coxiella burnetii. Fourteen skin biopsies were
performed (eschar = 6 and skin rash = 8); PCR
was positive in four cases (all taken from eschar),
DNA sequencing of the positive PCR products
gave 100% homology with Rickettsia conorii Ma-
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lish, and the same species was isolated from the
tick by culture.
Treatment and outcome
One hundred and one patients (85%) received
antibiotic treatment: doxycycline in 86 cases
(85%) and ciproﬂoxacin in 15 cases (15%). Severe
forms were noted in six cases (5%): lymphocytic
meningitis (three cases), meningoencephalitis
(one case), chorioretinitis and deafness (one case
each). However, no patient died and outcome was
favourable in all cases.
DISCUSSION
In this study, we have conﬁrmed the high fre-
quency of rickettsial infections among patients
with febrile illness in the centre of Tunisia during
summer. For the ﬁrst time in our country,
R. conorii Malish was identiﬁed by skin biopsy
PCR in humans. Although MSF was the most
common rickettsiosis, the cause of several cases of
SFG rickettsioses remain undetermined by serol-
ogy, and more skin biopsies are needed to
identify other species and to better understand
the epidemiology of rickettsial infections in Tuni-
sia. In contrast to Algeria, where the rate of
malignant forms and mortality were 42% and
3.2%, respectively [5], rickettsioses in our region
are benign diseases with a low rate of severe
forms and mortality.
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Table 1. Clinical features in adult hospitalised patients
Clinical data No. of patients (%)
Fever 119 (100)
Headache 82 (68.9)
Asthenia 63 (52.9)
Arthralgia 48 (40.3)
Myalgia 37 (31.2)
Cough 27 (22.7)
Nausea ⁄vomiting 25 (21)
Abdominal pain 11 (9.2)
Rash 102 (85.7)
Eschar 38 (31.9)
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